Overview
Jingmin Cheng practices practicing medicine in Taiyuan, China.
Their clinical expertise encompasses Pure Red Cell Aplasia.
They are actively involved in clinical research, co-authoring 16 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jingmin Cheng
Is Jingmin Cheng a top-rated expert for Pure Red Cell Aplasia?
MediFind is an objective health platform that identifies experts based on real-world data. Jingmin Cheng is classified as an Experienced expert for Pure Red Cell Aplasia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jingmin Cheng participate in research or clinical trials?
Yes. Jingmin Cheng has published 16 articles and abstracts on conditions like Pure Red Cell Aplasia. You can view a list of Jingmin Cheng's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers